Hologic Announces Second Quarter Fiscal 2015 Financial Results
By MedImaging International staff writers Posted on 10 May 2015 |
Hologic (Bedford, MA, USA), a global healthcare and diagnostics company, has announced revenues of USD 655.5 million for the second fiscal quarter ended March 28, 2015.
Revenues increased 4.9% on a reported basis, and 7.2% in constant currency. Hologic recorded a Generally Accepted Accounting Principles Earnings Per Share (GAAP EPS) of USD 0.17, a Non-GAAP EPS earnings per share of USD 0.41, and raised full-year revenue and earnings guidance. Non-GAAP earnings EPS rose to USD 0.41, an increase of 10.8%. Revenues grew in all Hologic business segments. International revenues declined to USD 160.3 million, but rose by 8.0%, on a constant currency basis.
Hologic develops, manufactures and supplies premium diagnostic and surgical products, and medical imaging systems for diagnostics, breast health, gynecology, surgical, and skeletal health.
Steve MacMillan, president and CEO of Hologic, said, "We posted strong organic revenue growth across the board for a second straight quarter, while profitability increased at an even faster rate. As a Company, we have come a long way in a short period of time. While we focus on continuing to improve our performance, we are increasingly confident in our people and products, and are therefore further raising our financial outlook for the year."
Related Links:
Hologic
Revenues increased 4.9% on a reported basis, and 7.2% in constant currency. Hologic recorded a Generally Accepted Accounting Principles Earnings Per Share (GAAP EPS) of USD 0.17, a Non-GAAP EPS earnings per share of USD 0.41, and raised full-year revenue and earnings guidance. Non-GAAP earnings EPS rose to USD 0.41, an increase of 10.8%. Revenues grew in all Hologic business segments. International revenues declined to USD 160.3 million, but rose by 8.0%, on a constant currency basis.
Hologic develops, manufactures and supplies premium diagnostic and surgical products, and medical imaging systems for diagnostics, breast health, gynecology, surgical, and skeletal health.
Steve MacMillan, president and CEO of Hologic, said, "We posted strong organic revenue growth across the board for a second straight quarter, while profitability increased at an even faster rate. As a Company, we have come a long way in a short period of time. While we focus on continuing to improve our performance, we are increasingly confident in our people and products, and are therefore further raising our financial outlook for the year."
Related Links:
Hologic
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures